Trial intelligence / Profile preview

Masitinib vs Methotrexate in Rheumatoid Arthritis

NCT01410695Phase 3Terminated

Sponsor
AB Science
Start
Jul 2011
Primary completion
Oct 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of masitinib in rheumatoid arthritis (RA), sponsored by AB Science. Started Jul 2011; status: terminated.

02

Drugs

masitinib
03

Conditions

rheumatoid arthritis (RA)

Beyond the preview

Go deeper on NCT01410695.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01410695.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call